| 查看: 1393 | 回复: 13 | |||
[交流]
美国 University of Nebraska-Lincoln 全奖招博士研究生 (Biomedical area)
|
|
Dr. Jiujiu Yu from the Department of Nutrition and Health Sciences at the University of Nebraska Lincoln is recruiting a highly-motivated Ph.D. student for Fall 2022. Our broad research interests are to 1) investigate the molecular mechanisms of NLRP3 inflammasome activation in the innate immune cells; 2) study the role of NLRP3 inflammasome-mediated chronic inflammation in obesity, aging, and liver diseases; and 3) identify new molecular nutraceuticals to suppress such inflammation (https://cehs.unl.edu/nhs/yu-lab/). Minimum qualification includes an M.S. or equivalent degree in biology, biochemistry, nutrition, or related field. Previous research experience in one or more of the following areas (obesity, liver diseases, extracellular vesicles, dietary molecules, mouse models, microbiome) is highly desirable. If interested, please submit your CV and personal statement to Dr. Yu at jyu18@unl.edu please indicate your GPA, TOEFL, and GRE scores in your application. Your application will not be considered without a personal statement or the aforementioned scores. Department requirement: Grade point average of 3.0 or higher on a 4.0 scale. Preferred minimum GRE scores: 145 Verbal; 150 Quantitative; 3.0 Analytical (writing). Required minimum TOEFL score (International students only): 550 paper; 79 internet; or 6.5 IELTS. https://cehs.unl.edu/nhs/graduate-programs/#tab0 |
» 猜你喜欢
生物学308求调剂(一志愿华东师大)
已经有6人回复
调剂求收留
已经有7人回复
272分材料子求调剂
已经有36人回复
275求调剂
已经有8人回复
一志愿211,化学学硕,310分,本科重点双非,求调剂
已经有20人回复
070300化学学硕311分求调剂
已经有19人回复
材料与化工调剂
已经有13人回复
材料与化工调剂
已经有33人回复
复试调剂
已经有7人回复
一志愿哈工大 085600 277 12材科基求调剂
已经有17人回复
蝉123456
新虫 (知名作家)
- 应助: 0 (幼儿园)
- 金币: 8997.4
- 散金: 8056
- 沙发: 17
- 帖子: 8548
- 在线: 80.6小时
- 虫号: 25711072
- 注册: 2021-03-08
- 专业: 计算机软件
2楼2022-02-03 19:32:33
3楼2022-02-05 06:09:36
4楼2022-02-06 11:46:10
5楼2022-02-07 01:41:04
6楼2022-02-09 03:10:13
7楼2022-02-10 03:58:07
8楼2022-02-10 23:34:59
9楼2022-02-12 00:00:36
10楼2022-02-13 08:50:05













回复此楼